BioCentury
ARTICLE | Politics & Policy

China issues guidance on biosimilars

March 7, 2015 2:23 AM UTC

China FDA's Center for Drug Evaluation has issued long-awaited biosimilars guidance that lays out basic principles for reviewing biosimilars in China.

The (see BioCentury Extra, Nov. 10). ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article